Scintigraphy with [111In]octreotide and 201Tl in a Hürthle cell thyroid carcinoma without detectable radio-iodine uptake. Report of a case and review of the literature
- PMID: 14530610
- DOI: 10.1159/000073234
Scintigraphy with [111In]octreotide and 201Tl in a Hürthle cell thyroid carcinoma without detectable radio-iodine uptake. Report of a case and review of the literature
Abstract
Aim: To describe the visualization of recurrent disease by [111In]octreotide and 201Tl scintigraphy in a patient with Hürthle cell thyroid carcinoma, increased thyroglobulin levels, and a negative radio-iodine total-body scan.
Methods: Scintigraphy with [111In]octreotide and 201Tl was performed, and a local recurrence in the thyroid bed was detected which was excised by surgery.
Results: On histology, the tumour proved to be a Hürthle cell carcinoma, and within the tumour somatostatin receptors were detected by RT-PCR.
Conclusion: Scintigraphy with [111In]octreotide and 201Tl is an alternative imaging method for the detection of residual disease in patients with a differentiated thyroid carcinoma having increased thyroglobulin levels and a negative radio-iodine total-body scan.
Copyright 2003 S. Karger AG, Basel
Similar articles
-
Expression of somatostatin receptors in oncocytic (Hürthle cell) neoplasia of the thyroid.Br J Cancer. 1999 Mar;79(9-10):1579-82. doi: 10.1038/sj.bjc.6690251. Br J Cancer. 1999. PMID: 10188909 Free PMC article.
-
Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation.Eur J Nucl Med. 1995 Nov;22(11):1330-8. doi: 10.1007/BF00801623. Eur J Nucl Med. 1995. PMID: 8575487
-
The relevance of somatostatin receptors in thyroid neoplasia.Yale J Biol Med. 1997 Sep-Dec;70(5-6):523-33. Yale J Biol Med. 1997. PMID: 9825479 Free PMC article. Clinical Trial.
-
Staging and treatment of differentiated thyroid carcinoma with radiolabeled somatostatin analogs.Trends Endocrinol Metab. 2006 Jan-Feb;17(1):19-25. doi: 10.1016/j.tem.2005.11.005. Epub 2005 Nov 28. Trends Endocrinol Metab. 2006. PMID: 16311041 Review.
-
Management of follicular and Hürthle cell neoplasms of the thyroid gland.Surg Oncol Clin N Am. 1998 Oct;7(4):893-910. Surg Oncol Clin N Am. 1998. PMID: 9735140 Review.
Cited by
-
Oncocytic Change in Thyroid Pathology.Front Endocrinol (Lausanne). 2021 May 3;12:678119. doi: 10.3389/fendo.2021.678119. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34012422 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical